Director Ossipow details SOPHiA GENETICS (SOPH) share, RSU and option holdings
Rhea-AI Filing Summary
SOPHiA GENETICS SA director Vincent Ossipow filed an initial ownership report showing 503,136 ordinary shares held directly, including 33,784 shares to be delivered under a restricted share unit award that vests at the next annual shareholder meeting.
He also holds fully vested, exercisable share options over 60,000 ordinary shares at an exercise price of $6.31 expiring on January 28, 2031, and options over 49,751 ordinary shares at $3.04 expiring on June 18, 2035.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Ossipow Vincent
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share Option (Right to Buy) | -- | -- | -- |
| holding | Share Option (Right to Buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Share Option (Right to Buy) — 109,751 shares (Direct);
Ordinary Shares — 503,136 shares (Direct)
Footnotes (3)
- F1. Includes 33,784 ordinary shares to be delivered in settlement of a restricted share unit award ("RSU"). Each RSU represents a contingent right to receive one ordinary share of the Issuer, vesting subject to the Reporting Person's continued service with the Issuer. The RSUs were granted on June 18, 2025 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders.
- F2. The share options are fully vested and exercisable.
- F3. The share options were granted on June 18, 2025 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders, subject to the Reporting Person's continued service to the Issuer through the relevant vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What stock options does Vincent Ossipow hold in SOPHiA GENETICS (SOPH)?
He holds fully vested share options over 60,000 ordinary shares at $6.31 expiring January 28, 2031, and options over 49,751 ordinary shares at $3.04 expiring June 18, 2035. These options can be exercised into ordinary shares before their expiration dates.
How many RSUs does Vincent Ossipow have in SOPHiA GENETICS (SOPH)?
The filing notes 33,784 ordinary shares will be delivered upon settlement of a restricted share unit award. Each RSU represents one ordinary share, vesting in full at the issuer’s next scheduled annual meeting of shareholders, subject to his continued service.
When do Vincent Ossipow’s SOPHiA GENETICS (SOPH) RSUs vest?
The restricted share units vest 100% as of the date of SOPHiA GENETICS’ next scheduled annual meeting of shareholders. Vesting is conditioned on Ossipow’s continued service with the company through that meeting, after which the RSUs settle into ordinary shares.
What does this Form 3 filing indicate about SOPHiA GENETICS (SOPH) insider ownership?
This Form 3 discloses Vincent Ossipow’s initial beneficial ownership as a director, detailing his ordinary shares, RSUs, and stock options. It establishes a baseline of his equity stake, but does not report any new purchases or sales.